These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16084853)

  • 1. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T; Shimizu M; Sugawara K; Tateishi T
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects.
    Kim KA; Park PW; Park JY
    Br J Clin Pharmacol; 2007 Jan; 63(1):53-8. PubMed ID: 16869811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M; Uno T; Sugawara K; Tateishi T
    Br J Clin Pharmacol; 2006 Sep; 62(3):372-6. PubMed ID: 16796706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T; Stoltz M; Weir S
    Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
    Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole and rifampin alter significantly the disposition and antihistamine effect of ebastine and its metabolites in healthy participants.
    Shon JH; Yeo CW; Liu KH; Lee SS; Cha IJ; Shin JG
    J Clin Pharmacol; 2010 Feb; 50(2):195-204. PubMed ID: 19841159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of fexofenadine enantiomers.
    Miura M; Uno T
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):69-74. PubMed ID: 19947891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
    Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
    J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M; Uno T; Sugawara K; Tateishi T
    Br J Clin Pharmacol; 2006 May; 61(5):538-44. PubMed ID: 16669847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics.
    Yamada S; Yasui-Furukori N; Akamine Y; Kaneko S; Uno T
    Ther Drug Monit; 2009 Dec; 31(6):764-8. PubMed ID: 19855315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
    Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
    Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
    Jones DH; Romero FA; Casale TB
    Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.